demonstrated for the frst time that, the antidiabetic prop erties of FGF21 is attributed with the inhibition of renal glucose reabsorption. This inhibitory role was found to be channeled through Peroxisome proliferator-activated recep tor delta (PPARδ) mediated sodium/glucose cotransporter 2 (SGLT2) pathway . Xu et al. also discovered that FGF21 signifcantly reduces the serum insulin level, glycosylated haemoglobin (HbA1c) level and the expressions of the hepatic gluconeogenesis genes such as glucose-6-phosphatase, G6Pase, and phosphoenolpyru vate carboxykinase (PCK), whilst upregulating the phospho rylation of STAT3 and suppressor of cytokine signaling 3 (SOCS3) in diabetic mice and dogs .